Choosing the best antipsychotic for individual patients with schizophrenia is challenging. A new meta-analysis seeks to inform that choice by ranking 32 antipsychotics on the basis of efficacy and safety.
Medscape Medical News
This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.